LEXINGTON, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences…
In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare DiseaseTwo Novel Radiopharma Clinical Trials now Active and…
BEIJING, Nov. 7, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn： The 2024 Shanghai City Investment Promotion Conference, held on Nov…
Fiscal Q2 2025 revenue of $26.3 million, net income of $0.1 million, operating income of $1.6 million, and Adjusted EBITDA*…
Q3 2024 Life Sciences Services revenue up 9% year-over-year, including BioStorage/BioServices revenue up 12% year-over-year Supported a record total of…
Top line results for JNJ-2113 Phase 3 ICONIC-LEAD and Phase 3 ICONIC-TOTAL clinical trials in patients with moderate to severe…
WELLINGTON, FL / ACCESSWIRE / November 7, 2024 / Dear Valued Shareholders,I am thrilled to share with you some of…
The women's health app market is driven by the growing awareness of women's health issues, increasing smartphone penetration, and the…
TEMPE, Ariz., Nov. 7, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in October for the 14th consecutive month…
With data from over 37,000 individuals across 50+ conditions, Health Union's 2024 syndicated healthcare research findings provide fresh perspectives on…